Daiichi Sankyo Bystander Effect - 搜索图片

1022×1004
logosandbrands.directory
Daiichi Sankyo « Logos & Brands Dire…
4500×1132
logo-logos.com
Daiichi Sankyo – Logo, brand and logotype
1200×627
pharmaphorum.com
Scotland says no to Daiichi Sankyo’s cholesterol drug Nilemdo | pharmaphorum
1280×720
vetores.org
Daiichi Sankyo SVG Logo – Vetores Grátis

2000×1333
bloomberg.com
Daiichi Sankyo Positions Its Covid Vaccine as a Booster in Japan - Blo…
1002×570
pharmaadvancement.com
Japan Approves Daiichi Sankyo Blood Cancer Drug Ezharmia
815×500
BioSpace
Daiichi Sankyo Abandons 6 Clinical Programs in Q1 Update | BioSpace
800×600
pharmaceutical-technology.com
Daiichi Sankyo in talks with AstraZeneca for Covid-19 vacc…

2000×1333
ydesign.hk
Daiichi Sankyo
1680×1120
Architizer
Daiichi-Sankyo by LPA Arquitetura e Consultoria - Architizer
474×355
seekingalpha.com
Daiichi Sankyo: There Is A Lot Of Room To Grow (OTCMKTS:DSKYF) | Seeking …

2208×1556
german-brand-award.com
Daiichi Sankyo - Winner Brand Communication - Print
720×720
cibh.be
Daiichi-Sankyo - CIBH - Community of Intersector…
1440×867
pharmaceutical-technology.com
Esperion and Daiichi Sankyo Europe amend partnership
2560×1707
ydesign.hk
Daiichi Sankyo

800×450
linkedin.com
Daiichi Sankyo on LinkedIn: #daiichisankyo #onedaiichisankyo
2560×1707
ydesign.hk
Daiichi Sankyo
2000×1333
The Japan Times
AstraZeneca bets $6.9 billion that Daiichi Sankyo therapy will transfor…
2560×1707
ydesign.hk
Daiichi Sankyo

1080×720
tr.linkedin.com
Daiichi Sankyo, Türkiye’de 10. Yılını Kutluyor
2560×1707
ydesign.hk
Daiichi Sankyo
1400×947
behance.net
Daiichi-Sankyo :: Behance
636×409
pharmafile.com
Daiichi Sankyo: breaking down barriers with social media - Pharmafile

某些结果已被隐藏，因为你可能无法访问这些结果。显示无法访问的结果